Studies have shown that the Hb level can be an independent predictor of prognosis in patients with colorectal cancer,11 gastric cancer,12 liver cancer,13 endometrial cancer,14 SCLC,5 and other cancers. This evidence concerns the gene GSTM1 and cancer.